Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international study

E.A. Coenen, S.C. Raimondi, J Harbott, M Zimmermann, T.A. Alonzo, A. Auvrignon, HB Beverloo, M. Chang, U. Creutzig, M.N. Dworzak, E. Forestier, B Gibson, H Hasle, C.J. Harrison, N.A. Heerema, G.J.L. Kaspers, A. Leszl, N. Litvinko, L. Lo Nigro, A. MorimotoC. Perot, D Reinhardt, J.E. Rubnitz, F.O. Smith, J Stary, I. Stasevich, S. Strehl, T. Taga, D. Tomizawa, D. Webb, Z. Zemanova, R. Pieters, C.M. Zwaan, M. van den Heuvel-Eibrink

Research output: Contribution to journalArticleAcademicpeer-review

53 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)7102-7111
JournalBlood
Volume117
Issue number26
DOIs
Publication statusPublished - 2011

Cite this